Home
About
Overview
Sharing Data
ORCID
Help
History (22)
Angiocardiography
Product Line Management
Serum 25-hydroxyvitamin d levels and C-reactive protein in persons with human immunodeficiency virus infection.
A twin study of sexual behavior in men.
The promise of CCR5 antagonists as new therapies for HIV-1.
See All 22 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The promise of CCR5 antagonists as new therapies for HIV-1.
Repik A, Richards KH, Clapham PR. The promise of CCR5 antagonists as new therapies for HIV-1. Curr Opin Investig Drugs. 2007 Feb; 8(2):130-9.
View in:
PubMed
subject areas
Animals
Anti-HIV Agents
CCR5 Receptor Antagonists
Drugs, Investigational
HIV Infections
HIV-1
Humans
Models, Biological
Molecular Structure
authors with profiles
Paul R Clapham PhD